Treatment Outcomes and Prognostic Factors of Acute Variceal Bleeding in Patients with Hepatocellular Carcinoma

다국어 초록 (Multilingual Abstract)

Background/Aims: The treatment outcomes and prognostic markers of acute variceal bleeding (AVB) in hepatocellular carcinoma (HCC) patients remain unclear. Therefore, we evaluated the clinical outcomes and prognostic factors of AVB in HCC patients. Methods: Cirrhotic patients with endoscopically confirmed AVB between 2007 and 2013 were enrolled in this prospective study. Prognostic factors were identified by multivariate Cox proportional hazards regression analysis. Results: Among the 329 enrolled patients, 125 patients (38.0%) were diagnosed with HCC. The 6-week mortality rates of all enrolled AVB patients and the HCC subgroup were 14.9% and 26.4%. The 5-day treatment failure, 6-week mortality, cirrhosis-related complications, and duration of hospitalization were greater in HCC patients than in non-HCC patients (all p<0.05). In the HCC subgroup, the Model for End-Stage Liver Disease (MELD) score (hazard ratio [HR], 1.145; p=0.001) and Barcelona Clinic Liver Cancer (BCLC) stage (C–D vs 0–B) (HR, 3.096; p=0.019) were independent predictors of 6-week mortality. Our study revealed that 85% of HCC patients with both a MELD score ≥15.5 and BCLC stage C–D died within 6 weeks, and the 6-week mortality risk was 21-fold higher in this group than in the group with a lower MELD score and earlier HCC stage (p<0.001). Conclusions: The 5-day treatment failure and 6-week mortality rates were significantly higher among AVB patients with HCC than those without HCC. The MELD score and the presence and stage of HCC are strong predictors of 6-week mortality in patients with AVB.

참고문헌 (Reference)

1 Lo EA, "Use of proton pump inhibitors in the management of gastroesophageal varices : a systematic review" 49 : 207-219, 2015

2 Amitrano L, "The effectiveness of current acute variceal bleed treatments in unselected cirrhotic patients : refining short-term prognosis and risk factors" 107 : 1872-1878, 2012

3 Graham DY, "The course of patients after variceal hemorrhage" 80 : 800-809, 1981

4 Jin Wook Chung, "Role of endoscopic treatment or balloon-occluded retrograde transvenous obliteration in patients with Child-Pugh class C end-stage liver cirrhosis and esophageal/gastric varices" 대한간학회 25 (25): 181-182, 2019

5 De Franchis R, "Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension" 53 : 762-768, 2010

6 Han ML, "Predictors of in-hospital mortality after acute variceal bleeding in patients with hepatocellular carcinoma and concurrent main portal vein thrombosis" 29 : 344-351, 2014

7 Bambha K, "Predictors of early re-bleeding and mortality after acute variceal haemorrhage in patients with cirrhosis" 57 : 814-820, 2008

8 Augustin S, "Predicting early mortality after acute variceal hemorrhage based on classification and regression tree analysis" 7 : 1347-1354, 2009

9 Wiesner R, "Model for end-stage liver disease(MELD)and allocation of donor livers" 124 : 91-96, 2003

10 Chalasani N, "Model for End-Stage Liver Disease(MELD)for predicting mortality in patients with acute variceal bleeding" 35 : 1282-1284, 2002

11 Garcia-Tsao G, "Management of varices and variceal hemorrhage in cirrhosis" 362 : 823-832, 2010

12 Amitrano L, "MELD score and hepatocellular carcinoma identify patients at different risk of short-term mortality among cirrhotics bleeding from esophageal varices" 42 : 820-825, 2005

13 Carbonell N, "Improved survival after variceal bleeding in patients with cirrhosis over the past two decades" 40 : 652-659, 2004

14 Chalasani N, "Improved patient survival after acute variceal bleeding : a multicenter, cohort study" 98 : 653-659, 2003

15 Forner A, "Hepatocellular carcinoma" 379 : 1245-1255, 2012

16 Abraldes JG, "Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy" 48 : 229-236, 2008

17 Idezuki Y, "General rules for recording endoscopic findings of esophagogastric varices (1991). Japanese Society for Portal Hypertension" 19 : 420-423, 1995

18 De Franchis R, "Evolving consensus in portal hypertension : report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension" 43 : 167-176, 2005

19 Augustin S, "Effectiveness of combined pharmacologic and ligation therapy in high-risk patients with acute esophageal variceal bleeding" 106 : 1787-1795, 2011

20 García-Pagán JC, "Early use of TIPS in patients with cirrhosis and variceal bleeding" 362 : 2370-2379, 2010

21 Sarin SK, "Diagnosis and management of acute variceal bleeding : Asian Pacific Association for Study of the Liver recommendations" 5 : 607-624, 2011

22 Chen PH, "Delayed endoscopy increases re-bleeding and mortality in patients with hematemesis and active esophageal variceal bleeding : a cohort study" 57 : 1207-1213, 2012

23 Lo GH, "Controlled trial of ligation plus vasoconstrictor versus proton pump inhibitor in the control of acute esophageal variceal bleeding" 28 : 684-689, 2013

24 Hou MC, "Clinical implications of the white nipple sign and its role in the diagnosis of esophageal variceal hemorrhage" 91 : 2103-2109, 1996

25 Jairath V, "Acute variceal haemorrhage in the United Kingdom : patient characteristics, management and outcomes in a nationwide audit" 46 : 419-426, 2014

26 Lecleire S, "Acute upper gastrointestinal bleeding in patients with liver cirrhosis and in noncirrhotic patients : epidemiology and predictive factors of mortality in a prospective multicenter population-based study" 39 : 321-327, 2005

27 Reverter E, "A MELD-based model to determine risk of mortality among patients with acute variceal bleeding" 146 : 412-419, 2014